Quick Links

 Cancer and Aging Research Program

Cancer and Aging Research ProgramThe mission of the City of Hope Cancer and Aging Research Program is to join investigators from all cancer disciplines to study the biology, treatment, and survivorship issues which face older adults with cancer. The results of this research will be applicable to the majority of patients with cancer because approximately 60% of cancer diagnoses and 70% of cancer mortality occur in patients over the age of 65.

The number of older patients with cancer and cancer survivors is rapidly growing because the U.S. population is aging with a projected doubling in the number of patients 65 and older by 2030. Although the majority of cancers occur in older adults, these patients have been under-represented on the national cancer clinical trials which set the standards for oncology care. Few studies have specifically focused on the unique issues which face older adults such as the impact of age related declines in physiology, polypharmacy, or comorbid medical conditions on treatment tolerance.

Research Focus

  • Role of Geriatric Assessment in the care of the older patient with cancer (understanding an individual’s physiologic age verses chronological age) 
  • Adjuvant treatment decisions in older patients with breast cancer
  • Cognitive effects of cancer therapy in older cancer patients
  • Pharmacokinetics of cancer therapy with aging

 Contact Us

For more information about City of Hope's Cancer and Aging Research Program, contact:

Arti Hurria, M.D.
Director
626-256-HOPE (4673), ext. 64173
ahurria@coh.org

Kayo Tagawa
Biostatistician

Vani Katheria
Clinical Research Assistant

Rupal Ramani
Clinical Research Assistant
  
Lilia Palomo
Regulatory Coordinator

Dawnyetta Reese
Senior Secretary

Kathy Malley
Senior Secretary


 

 Search

Go!
Advanced Search Options
News & Publications Search

 Clinical Trials

Our aggressive pursuit to discover better ways to help patients now – not years from now – places us among the leaders worldwide in the administration of clinical trials. Last year, City of Hope conducted more than 300 studies enrolling more than 5,000 patients. Find out more about City of Hope's Clinical Trials.

NCI CCC LogoCity of Hope is one of 40 Comprehensive Cancer Centers, the highest designation bestowed by the National Cancer Institute and a recognition of excellence in cancer treatment, research, prevention and education.
City of Hope strongly supports and values the uniqueness of all individuals and promotes a work environment where diversity is embraced.
NCI CCC LogoThe National Comprehensive Cancer Network®
(NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HON code of the Healthcare on the Net Foundation.